We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-5.07 | -0.68% | 740.8789 | 14,454 | 13:25:00 |
By Adriano Marchese
Eli Lilly & Co. said Wednesday that the U.S. government has purchased 650,000 additional doses of its Bamlanivimab drug in the treatment of Covid-19 for $812.5 million.
The Indianapolis-based company said doses will be delivered through Jan. 31, with at least 350,000 of the additional doses to be delivered in December.
Bamlanivimab recently received emergency-use authorization for the treatment of mild-to-moderate Covid-19 in patients at risk of it progressing to severe.
The order brings the total purchase by the U.S. government to 950,000 doses, the company said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 02, 2020 16:59 ET (21:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions